Company Dendreon Corporation
Equities
US24823Q1076
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | Endo : Drugmaker Valeant close to buying Salix - source | RE |
2015 | Dendreon : Valeant secures financing for potential Salix bid: Bloomberg | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 158,716,893 | 153,327,147 ( 96.60 %) | 0 | 96.60 % |
Company contact information
Dendreon Corp.
1208 Eastlake Avenue East
98102, Seattle
+206-256-4545
Sector
1st Jan change | Capi. | |
---|---|---|
+31.89% | 49.46B | |
+1.67% | 42.58B | |
+48.94% | 42.49B | |
-5.26% | 29.09B | |
+12.61% | 26.61B | |
-23.78% | 18.64B | |
+8.06% | 13.16B | |
+30.74% | 12.55B | |
+24.13% | 12.1B |
- Stock Market
- Equities
- Stock
- Company Dendreon Corporation